Loss of factor VIII activity during storage in PVC containers due to adsorption

Haemophilia

Volumn 6, Issue 2, 2000, Pages 89-92

  Mcleod, A G ^a   Walker, I R ^a   Zheng, S ^a   Hayward, C P M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Continuous infusion; Factor VIII; FVIII concentrate; Haemophilia; In vitro stability; Therapy

Indexed keywords

ANTIBODY; DETERGENT; INFUSION FLUID; POLYVINYLCHLORIDE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADSORPTION; ARTICLE; CONTAINER; CONTROLLED STUDY; DILUTION; DRUG INFUSION; DRUG STABILITY; DRUG STORAGE; ECONOMIC ASPECT; IMMUNOBLOTTING; PRIORITY JOURNAL;

ADSORPTION; DRUG PACKAGING; DRUG STABILITY; EQUIPMENT AND SUPPLIES, HOSPITAL; FACTOR VIII; HUMANS; IMMUNOBLOTTING; POLYPROPYLENES; POLYVINYL CHLORIDE; REFERENCE STANDARDS; SYRINGES; TIME FACTORS;

EID: 0034061221     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00382.x     Document Type: Article

References (11)

1. McMillan CW, Webster WP, Roberts HR, Blythe WB. Continuous intravenous infusion of factor VIII in classic haemophilia. Br J Haematol 1970; 18: 659-67.
2. Hathaway HE, Christian MJ, Clarke SJ, Hasiba U. Comparison of continuous and intermittent factor VIII concentrate therapy in haemophilia A. Am J Hematol 1984; 17: 85-8.
3. Bona RD, Weinstien RE, Weisman SJ, Bartolomeo A, Rickles FR. The use of continuous infusion of factor concentrates in the treatment of haemophilia. Am J Hematol 1989; 32: 8-13.
4. Weinstein RE, Bona RD, Rickles FR. Continuous infusion of monoclonal antibody-purified factor VIII. Am J Hematol 1991; 36: 211-2.
5. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
6. Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Monoclonal purified FVIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost 1994; 72: 403-7.
7. Schulman S, Gitel S, Martinowitz U. Stability of factor VIII concentrates after reconstitution. Am J Hematol 1994; 45: 217-23.
8. Hurst D, Miller D, Zabor D, Malianni D. Evaluation of recombinant factor VIII (Kogenate) stability for continuous infusion using a mini-pump infusion device. Haemophilia 1996; 2 (Suppl. 1): 54.
9. Schulman S, Keller N, Gitel SN, Ravid B, Varon D. The suitability of recombinant F VIII (Kogenate) for continuous infusion-stability and bacteriological safety. Blood 1995; 86 (Suppl. 1): 185.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
11. DiMichele DM, Lasak ME, Miller CH. In vitro factor VIII recovery during the delivery of ultra-pure factor VIII concentrate by continuous infusion. Am J Hematol 1996; 51: 99-103.